/REGULATORY AFFAIRS / ACTIVITIES

EVENTS

SOCIAL MEDIA

TWITTER

ACTIVITIES

  • STEPs MEPs Interest Group
    These activities involved tabling amendments and setting up bilateral meetings with different rapporteurs and shadow rapporteurs working on the dossiers.
  • Clinical Trials
    The legal framework in Europe needs adapting, not only to permit easier access to smaller groups of subjects, but also to recognise the validity of results from trials much smaller than the classic randomised approach.
  • In-Vitro Diagnostics
    The revision of the EU In Vitro Diagnostics Directive presents an opportunity for strengthening the current approval system for IVDs for the sake of patient safety, competitiveness and innovation. To ensure that the final outcome of the ongoing discussion is a well-performing approval system, several points specific to IVDs should be considered carefully.
  • Data Protection
    EAPM believes it is vital that our doctors have access to the best information and diagnostic techniques available. Today's emerging technologies, such as analytics tools for "Big Data", can help healthcare professionals improve diagnoses and reshape the way medicine is practiced.
  • MAPPS
    MAPPs and its associated areas of applied research funding will be a major area of focus across the EU for the next five years.

SOCIAL MEDIA